Corien de Groot - Eckhardt

Research output

Research output per year 2009 2009 2014 2015 2016 2017 2020 2023

• 16 Article
• 2 Comment/Letter to the editor
• 1 Review article
• 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2023

  Impact of hospitalization for vaso-occlusive crisis on health-related quality of life in children with sickle cell disease

  Vuong, C., Moussa, I., van Muilekom, M. M., Heijboer, H., Rettenbacher, E., Haverman, L., Twisk, J., Fijnvandraat, K. & Eckhardt, C. L., Dec 2023, In: Pediatric Blood and Cancer. 70, 12, e30691.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
• 2022

  Diagnostic Value of a Protocolized In-Depth Evaluation of Pediatric Bone Marrow Failure: A Multi-Center Prospective Cohort Study

  Atmar, K., Ruivenkamp, C. A. L., Hooimeijer, L., Nibbeling, E. A. R., Eckhardt, C. L., Huisman, E. J., Lankester, A. C., Bartels, M., Santen, G. W. E., Smiers, F. J., van der Burg, M. & Mohseny, A. B., 27 Apr 2022, In: Frontiers in immunology. 13, 883826.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)
• 2021

  Treatment-related risk factors for inhibitor development in non-severe hemophilia A after 50 cumulative exposure days: A case-control study

  the INSIGHT Study Group, Sept 2021, In: Journal of thrombosis and haemostasis. 19, 9, p. 2171-2181 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  7 Citations (Scopus)
• 2020

  Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case‒control study

  the INSIGHT consortium, 1 Jun 2020, In: British journal of haematology. 189, 6, p. 1182-1191 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• The factor VIII treatment history of non-severe hemophilia A

  Abdi, A., Kloosterman, F. R., Eckhardt, C. L., Male, C., Castaman, G., Fischer, K., Beckers, E. A. M., Kruip, M. J. H. A., Peerlinck, K., Mancuso, M. E., Santoro, C., Hay, C. R., Platokouki, H., van der Bom, J. G., Gouw, S. C., Fijnvandraat, K. & Hart, D. P., Dec 2020, In: Journal of thrombosis and haemostasis. 18, 12, p. 3203-3210 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  13 Citations (Scopus)
• 2017

  Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: results of the INSIGHT case-control study

  van Velzen, A. S., Eckhardt, C. L., Peters, M., Leebeek, F. W. G., Escuriola-Ettingshausen, C., Hermans, C., Keenan, R., Astermark, J., Male, C., Peerlinck, K., le Cessie, S., van der Bom, J. G. & Fijnvandraat, K., 2017, In: Journal of thrombosis and haemostasis. 15, 7, p. 1422-1429

  Research output: Contribution to journal › Article › Academic › peer-review
  24 Citations (Scopus)

• Mortality caused by intracranial bleeding in non-severe hemophilia A patients

  Loomans, J. I., Eckhardt, C. L., Reitter-Pfoertner, S. E., Holmström, M., van Gorkom, B. L., Leebeek, F. W. G., Santoro, C., Haya, S., Meijer, K., Nijziel, M. R., van der Bom, J. G. & Fijnvandraat, K., 2017, In: Journal of thrombosis and haemostasis. 15, 6, p. 1115-1122

  Research output: Contribution to journal › Article › Academic › peer-review
  17 Citations (Scopus)

• Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations

  Loomans, J. I., van Velzen, A. S., Eckhardt, C. L., Peters, M., Mäkipernaa, A., Holmstrom, M., Brons, P. P., Dors, N., Haya, S., Voorberg, J., van der Bom, J. G. & Fijnvandraat, K., 2017, In: Journal of thrombosis and haemostasis. 15, 2, p. 246-254

  Research output: Contribution to journal › Article › Academic › peer-review
  23 Citations (Scopus)
• 2016

  The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors

  AUTHOR GROUP, 2016, In: Thrombosis and haemostasis. 115, 3, p. 543-550

  Research output: Contribution to journal › Article › Academic › peer-review
  24 Citations (Scopus)
• 2015

  Inhibitor development and mortality in non-severe hemophilia A

  AUTHOR GROUP, 2015, In: Journal of thrombosis and haemostasis. 13, 7, p. 1217-1225

  Research output: Contribution to journal › Article › Academic › peer-review
  61 Citations (Scopus)

• Inhibitors in nonsevere haemophilia A: outcome and eradication strategies

  van Velzen, A. S., Eckhardt, C. L., Hart, D. P., Peters, M., Rangarajan, S., Mancuso, M. E., Smiers, F. J., Khair, K., Petrini, P., Jiménez-Yuste, V., Hay, C. R. M., van der Bom, J. G., Yee, T. T. & Fijnvandraat, K., 2015, In: Thrombosis and haemostasis. 114, 1, p. 46-55

  Research output: Contribution to journal › Article › Academic › peer-review
  33 Citations (Scopus)
• 2014

  The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

  Eckhardt, C. L., Astermark, J., Nagelkerke, S. Q., Geissler, J., Tanck, M. W. T., Peters, M., Fijnvandraat, K. & Kuijpers, T. W., 2014, In: Journal of thrombosis and haemostasis. 12, 8, p. 1294-1301

  Research output: Contribution to journal › Article › Academic › peer-review
  22 Citations (Scopus)
• 2013

  Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A

  Eckhardt, C. L., van Velzen, A. S., Peters, M., Astermark, J., Brons, P. P., Castaman, G., Cnossen, M. H., Dors, N., Escuriola-Ettingshausen, C., Hamulyak, K., Hart, D. P., Hay, C. R. M., Haya, S., van Heerde, W. L., Hermans, C., Holmström, M., Jimenez-Yuste, V., Keenan, R. D., Klamroth, R., Laros-van Gorkom, B. A. P., & 25 othersLeebeek, F. W. G., Liesner, R., Mäkipernaa, A., Male, C., Mauser-Bunschoten, E., Mazzucconi, M. G., McRae, S., Meijer, K., Mitchell, M., Morfini, M., Nijziel, M., Oldenburg, J., Peerlinck, K., Petrini, P., Platokouki, H., Reitter-Pfoertner, S. E., Santagostino, E., Schinco, P., Smiers, F. J., Siegmund, B., Tagliaferri, A., Yee, T. T., Kamphuisen, P. W., van der Bom, J. G. & Fijnvandraat, K., 2013, In: Blood. 122, 11, p. 1954-1962

  Research output: Contribution to journal › Article › Academic › peer-review
  178 Citations (Scopus)
• 2012

  Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A: a prospective national study in the Netherlands

  Eckhardt, C. L., Mauser-Bunschoten, E. P., Peters, M., Leebeek, F. W. G., van der Meer, F. J. M. & Fijnvandraat, K., 2012, In: British journal of haematology. 157, 6, p. 747-752

  Research output: Contribution to journal › Article › Academic › peer-review
  23 Citations (Scopus)
• 2009

  Intensive peri-operative use of factor VIII and the Arg593-->Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A

  Eckhardt, C. L., Menke, L. A., van Ommen, C. H., van der Lee, J. H., Geskus, R. B., Kamphuisen, P. W., Peters, M. & Fijnvandraat, K., 2009, In: Journal of thrombosis and haemostasis. 7, 6, p. 930-937

  Research output: Contribution to journal › Article › Academic › peer-review
  93 Citations (Scopus)

• New insights in the cause of inhibitor development in hemophilia A: the Arg593->Cys mutation and high dose of factor VIII may be the culprits.

  Eckhardt, C. L., Menke, L. M., van Ommen, C. H., van der Lee, J. H., Geskus, R. B., Kamphuisen, P. W., Peters, M. & Fijnvandraat, K., 2009, In: Pediatric clinics Amsterdam. 20, 2, p. 8-10

  Research output: Contribution to journal › Article › Academic › peer-review